{"id":"W2619012808","doi":"10.1080/10428194.2017.1326034","title":"Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus","year":2017,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Janssen Research and Development","keywords":"Ibrutinib; Mantle cell lymphoma; Temsirolimus; Medicine; Quality of life (healthcare); Internal medicine; Oncology; Clinical trial; Lymphoma; Phases of clinical research; Randomized controlled trial; Leukemia; Discovery and development of mTOR inhibitors; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002453384,0.001336979,0.004378041,0.0006026786,0.0006866151,0.0006451206,0.003384061,0.0005585453,0.0001665424],"category_scores_gemma":[0.00132791,0.000999423,0.0001859456,0.0006492258,0.001427143,0.00145495,0.002250296,0.0003002699,0.00005975486],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02914103,"about_ca_system_score_gemma":0.02140929,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1843833,"about_ca_topic_score_gemma":0.005552835,"domain_scores_codex":[0.98915,0.001259861,0.003154353,0.00270651,0.002130578,0.001598731],"domain_scores_gemma":[0.9886148,0.001485085,0.002759629,0.005250993,0.0006717151,0.001217805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7067419,0.01671436,0.2405799,0.0004664761,0.003323556,0.0008575378,0.002134367,0.00001776189,0.00008584744,0.00002676121,0.0007573385,0.02829421],"study_design_scores_gemma":[0.7471001,0.003589409,0.2278134,0.0008736168,0.0006802783,0.00003596252,0.0006215097,0.01791709,0.0002528887,0.000007148583,0.0002745621,0.0008341041],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862601,0.001005355,0.00001546281,0.0001888115,0.0003081269,0.00840022,0.0009275394,0.0001690429,0.002725384],"genre_scores_gemma":[0.9939965,0.0005136609,0.0004945311,0.0002667889,0.0001318994,0.0004199527,0.003120015,0.0002484664,0.0008082056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1788305,"threshold_uncertainty_score":0.9999381,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07370496193561728,"score_gpt":0.3693687295541824,"score_spread":0.2956637676185651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}